2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
April 25th 2022
Peter Riedell, MD, discusses the use of axicabtagene ciloleucel in high-risk large B-cell lymphoma, as evaluated on the phase 2 ZUMA-12 trial.
January 11th 2022
Peter Riedell, MD, discusses unique data points of a landmark analysis conducted in mantle cell lymphoma.
December 22nd 2021
Peter Riedell, MD, discusses the patient population and design of a dynamic landmark analysis conducted in patients with mantle cell lymphoma.
December 21st 2021
Peter Riedell, MD, discusses the effects of time to relapse on outcomes in mantle cell lymphoma.